A pilot study of CS-1008, a humanized monoclonal antibod

  • Skubitz, Keith (PI)

Project: Research project

Project Details

Description

A pilot study of CS-1008, a humanized monoclonal antibody targeting death receptor 5, alone or in combination with imatinib mesylate or sunitinib
StatusFinished
Effective start/end date9/25/07 → 12/31/10

Funding

  • DAIICHI SANKYO PHARM DEV
View all
View less

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.